Fidelity & Guaranty Life Insurance Co. sold a total of 59,286 shares of Crescent Capital BDC, Inc. for approximately $628,590 in transactions executed on August 26 and 27, 2026.
The insurer disposed of 32,091 shares at a volume-weighted average price of $10.6013 on August 26, with individual trades ranging from $10.60 to $10.625. On August 27, Fidelity & Guaranty Life sold an additional 27,195 shares at an average price of $10.6043, with prices between $10.60 and $10.67 per share.
Following the disposals, the company’s remaining beneficial ownership in Crescent Capital BDC stands at 4,072,564 common shares, held indirectly through its wholly-owned subsidiary, Fidelity & Guaranty Life Insurance Company of New York. Crescent Capital BDC, which trades under the ticker CCAP on the NASDAQ, is a business development company.
Crescent Capital BDC reported Q2 2026 net investment income of $0.36 per share, slightly below the Wall Street consensus estimate of $0.3667 per share. The company’s revenue also fell short of projections, though its net investment income remained sufficient to cover its base dividend of $0.34 per share and support a previously announced special payout.
Analysts at Keefe, Bruyette & Woods downgraded Crescent Capital BDC’s stock from Outperform to Market Perform, citing a 2.5% decline in net asset value and deteriorating credit quality over the past two years. The firm also reduced its price target from $13.00 to $12.00.
